Full length article| Volume 242, P150-158, November 2019

Download started.


Adjunctive use of tranexamic acid to tourniquet in reducing haemorrhage during abdominal myomectomy - A randomized controlled trial

Published:September 25, 2019DOI:



      Uterine fibroids are the commonest tumour of the female genital tract; about one third are symptomatic and require management. The treatment of uterine fibroids may be medical, surgical, conservative or expectant. Myomectomy is the common surgical treatment option for women failing medical management and desiring to preserve fertility and/or their uterus. The tourniquet is shown to be effective in reducing blood loss during myomectomy and tranexamic to a less extent. However, the adjunctive use of tranexamic acid with tourniquet to further reduce blood loss has not been studied.


      The aim of the study was to determine the efficacy of perioperative intravenous tranexamic acid in further reducing blood loss at abdominal myomectomy when used as an adjunct to tourniquet.


      The study was a randomized double-blind controlled study involving women who underwent abdominal myomectomy. Participants were randomized to either tourniquet plus intravenous tranexamic acid or tourniquet plus placebo groups using simple random sampling. The primary outcomes were the intra-operative blood loss, post-operative haematocrit values and need for intra-operative blood transfusion. The data was analyzed using the SPSS software version 23.0 and p value < 0.05 was significant.


      The mean intra-operative blood loss (998.72 ± 607.21 ml vs 907.25 ± 529.85 ml, p = 0.475), intra-operative blood transfusion rate (45% vs. 30%; p = 0.166) and mean unit of blood transfused (1.13 ± 1.64 vs. 0.75 ± 1.28; p = 0.256) were higher for tourniquet plus placebo group compared to tourniquet plus tranexamic acid group. The estimated blood loss per 100 g of fibroid removed was reduced significantly in the tranexamic acid plus tourniquet group (139.80 ± 2.28 ml vs 104.09 ± 1.97 ml; p = 0.001).

      Strength and limitations

      : The strength of the study include randomization and blinding. The limitations included non-uniformity of sizes and locations of fibroids, as well as the different surgeons with possibly different skills, techniques and experiences, though they were statistically not significant.


      The adjunctive use of tranexamic acid to tourniquet significantly further reduces intraoperative blood loss during abdominal myomectomy when compared to tourniquet alone.


      Adjunctive use of tranexamic acid is recommended for further reducing intra-operative blood loss during abdominal myomectomy.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Panagliotis P.
        • Anna K.
        Tranexamic acid for the management of uterine fibroid tumors: a systematic review of the current evidence.
        World J Clin Cases. 2014; 2: 893-898
        • Wallach E.E.
        • Vlahos N.F.
        Uterine myomas: an overview of development, clinical features, and management.
        Obstet Gynecol. 2004; 104 ([PubMed]): 393-406
        • Fibroids
        Jacqueline Payne.
        2015 (at Accessed on January 25th, 2016. 20 Jan)
        • Committee on Gynecologic Practice
        American college of obstetricians and gynecologists. ACOG committee opinion. Uterine artery embolization.
        Obstet Gynecol. 2004; 103: 403-404
        • Al-Shabibi N.
        • Chapman L.
        • Madari S.
        • Papadimitriou A.
        • Papalampros P.
        • Magos A.
        Prospective randomized trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy.
        BJOG. 2009; 116: 681-687
        • Kwawukume E.Y.
        Leiomyoma of the uterus.
        in: Kwawukume E.Y. Emuveyan E.E. Comprehensive gynaecology in the tropics. Asante and Hitscher. Accra, 2005: 124-137
        • Ikechebelu J.I.
        • Zeama C.O.
        • Obiechina N.J.A.
        The use of tourniquet to reduce blood loss at myomectomy.
        Niger J Clin Pract. 2010; 13: 154-158
        • Adesina K.T.
        • Owolabi B.O.
        • Raji H.O.
        • Olarinoye A.O.
        Abdominal myomectomy: a retrospective review of determinants and outcomes of complications at the university of ilorin teaching hospital, Ilorin, Nigeria.
        Malawi Med J. 2017; 29: 37-42
        • Kongyuy E.J.
        • Wiysonge C.S.
        Interventions to reduce haemorrhage during myomectomy for fibroids.
        Cochrane Database of System Review. 2014;
        • Fusca L.
        • Perelman I.
        • Fergusson D.
        • Boutet M.
        • Chen I.
        The effectiveness of tranexamic acid at reducing blood loss and transfusion requirement for women undergoing myomectomy: a systematic review and meta-analysis.
        J Obstet Gynaecol Canada. 2019; 41: 1185-1192
        • Alptekin H.
        • Efe D.
        Effectiveness of pericervical tourniquet by Foley catheter reducing blood loss At abdominal myomectomy.
        Clin Exp Obstet Gynecol. 2014; 41: 440-444
        • Sammy N.
        • Timona O.
        • William S.
        Intravenous tranexamic acid as an adjunct haemostat to ornipressin during open myomectomy. A randomized double-blind placebo-controlled trial.
        Ann Surg Innov Res. 2015; 9: 10
        • Thorsen S.
        • Clemmenson I.
        • Sottrup-Jensen L.
        Adsorption to fibrin of native fragments of known primary structure from human plasminogen.
        Biochim Biohys Acta. 1981; 668: 377-387
        • Callender S.T.
        • Warner G.T.
        • Cope E.
        Treatment of menorrhagia with tranexamic acid: a double-blind trial.
        Br Med J. 1970; 4: 214-216
        • Brown R.S.
        • Thwaites B.K.
        • Mongan P.D.
        Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial.
        Anesth Analg Journ Obstet Gynecol. 1997; 85: 963-970
        • Gleeson N.C.
        • Buggy F.
        • Sheppard B.L.
        • Bonnar J.
        The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.
        Acta Obstet Gynecol Scand. 1994; 73: 274-277
        • Ido K.
        • Neo M.
        • Asada Y.
        • Kondo K.
        • Morita T.
        • Sakamoto T.
        • et al.
        Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties.
        Arch Orthop Trauma Surg. 2000; 120: 518-520
        • Wellington K.
        • Wagstaff A.J.
        Tranexamic acid: a review of its use in the management of menorrhagia.
        Drugs. 2003; 63: 1417-1433
        • Dunn C.J.
        • Goa K.L.
        Tranexamic acid: a review of its use in surgery and other indications.
        Drugs. 1999; 57: 1005-1032
        • Ip P.P.
        • Lam K.W.
        • Cheung C.L.
        • Yeung M.C.
        • Pun T.C.
        • Chan Q.K.
        • et al.
        Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas.
        Am J Surg Pathol. 2007; 31: 1215-1224
        • Eder S.
        • Baker J.
        • Gersten J.
        • Mabey R.G.
        • Adomako T.L.
        Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids.
        Women Health (Lond Engl). 2013; 9: 397-403
        • Lukes A.S.
        • Moore K.A.
        • Muse K.N.
        • Gersten J.K.
        • Hecht B.R.
        • Edlund M.
        • et al.
        Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial.
        Obstet Gynecol. 2010; 116: 865-875
        • Peitsidis P.
        • Kadir R.A.
        Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
        Expert Opin Pharmacother. 2011; 12: 503-516
        • Caglar G.S.
        • Tasci Y.
        • Kayikcioglu F.
        • Haberal A.
        Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo-controlled study.
        Eur J Obstet Gynecol Reprod Biol. 2008; 137: 227-231
        • Vitello D.J.
        • Ripper R.M.
        • Fettiplace M.R.
        • Weinberg G.L.
        • Vitello J.M.
        Blood density is nearly equal to water density: a validation study of the gravimetric method of measuring intraoperative blood loss.
        J Vet Med. 2015; 2015: 1-4
        • Wang Dongdong M.M.
        • et al.
        The efficiency and safety of tranexamic acid for reducing blood loss in open myomectomy. A meta-analysis of randomized controlled trials.
        Medicine. 2017; 96: e7072
        • Shaaban M.M.
        • Ahmed M.R.
        • Farhan R.E.
        • Dardeer H.H.
        Efficacy of tranexamic acid on myomectomy-associated blood loss in patients with multiple myomas. A randomized controlled clinical trial.
        Sci in the Serv of women’s Hlth. 2015; 23: 908-912
        • Opoku-Anane J.
        • Vargas M.V.
        • Moawad G.
        • Cherie M.
        • Robinson J.K.
        Use of intravenous tranexamic acid during myomectomy: a randomized double-blind placebo controlled trial.
        Journal minimally invasive gynaecology. 2015; 22: S197
        • Ukwenya V.
        • Nwakaego M.
        • Afolayan O.
        • Alese O.
        • Thomas W.
        Prevalence of uterine fibroid in a South-Western Nigerian population: a sonographic study.
        JECA. 2015; 14: 24-29
      1. Gynaecologic myomectomy. Available at http//: Accessed March 3rd, 2016.